Company intelligence / Profile preview

Idea International

Ownership: Private
Development stage: Other

Overview

IDEA Pharma is a leading pharmaceutical strategy consultancy specializing in early lifecycle product positioning and path-to-market strategies. The company has contributed to the strategic direction of eight out of the top 15 pharma product launches between 2015 and 2020, including major launches such as Opdivo and Ocrevus. They are recognized for their expertise in maximizing commercial success for new medicines by working with clients from early development through launch. Their annual Pharmaceutical Innovation Index is widely cited across the industry.

Industry: Consulting

Partnerships

Works with major global pharmaceutical companies on product launch strategies; specific partners are confidential but include involvement with products from Roche and others.

Beyond the preview

Go deeper on Idea International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Idea International.

Explore the full profile